38 results on '"Elliott, Mitchell"'
Search Results
2. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages
3. Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
4. Improving dihydropyrimidine dehydrogenase genotyping (DPYD) prior to initiation of fluoropyrimidine-based chemotherapy at a community-based hospital: A quality improvement initiative.
5. Comparative overall survival of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer
6. Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study
7. Camping Adventure
8. Abstract P6-01-16: Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
9. Pre-diagnosis plasma cell-free DNA methylome profiling up to seven years prior to clinical detection reveals early signatures of breast cancer
10. The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism
11. A Comparative Study of Music Mastered by Human Engineers and Automated Services
12. The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor–resistant ER + breast cancer with mitotic aberrations
13. Current Treatment and Future Trends of Immunotherapy in Breast Cancer
14. Real-world outcomes of patients with human epidermal growth factor 2 (HER2)–positive breast cancer receiving neoadjuvant therapy without adjuvant ado-trastuzumab emtansine (T-DM1).
15. Development of novel agents for the treatment of early estrogen receptor positive breast cancer
16. Prioritising access to cancer drugs
17. Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations
18. Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations.
19. Symbolic Factorization Re-utilization for Contingency Analysis
20. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation
21. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation.
22. Optimal wind farm placement considering system constraints and investment and uncertainty costs
23. Building Healthcare in a Coastal Environment.
24. A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD).
25. Impact of pathogenic germline BRCA1/2 and PALB2 mutations and tumor aneuploidy in patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.
26. Comparative overall survival of patients in trials of CKD4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.
27. Forced Entry The Dread of Rape in Women and in Men.
28. Superego-Based Physical Symptoms.
29. Big Springs
30. The Topographic Map of the United States
31. America's Resources in Nitrogen, Potash and Phosphorus
32. SPOTLIGHT ON NFPA Health Care Section.
33. The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.
34. Ionizable Drugs Enable Intracellular Delivery of Co-Formulated siRNA.
35. Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging Guidelines.
36. Current Treatment and Future Trends of Immunotherapy in Breast Cancer.
37. HIT investment pays off.
38. Choosing a vendor for HIT. A multifacility provider seeks a vendor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.